Adequate funding is crucial in the fight against tuberculosis, but progress worldwide is threatened by underinvestment in tuberculosis research and development.

Jigna Rao, patient advocate, speaks about patient centered approaches to cure at the TAG symposium “Cascades: Improving TB Care”, held on November 1 during the 2013 Union World Conference on Lung Health in Paris, France.

The CRAG is giving Sanofi one week to respond to the community demands, or will escalate action!

Grania Brigden, TB advisor to the MSF Campaign for Access to Essential Medicines, describes how the current drug R&D model is failing TB patients.

Two young women are proving to the world that the most deadly strain of TB can be beaten.

European Union institutions and international donors cannot turn a blind eye to the TB and HIV epidemics occurring in the greater European region.

"The Indian government continues to deny that there are drug stockouts. Innocent children are dying when people continue to say that there are no stockouts."

New TB drug bedaquiline illustrates need for paradigm shift in developing and ensuring accessto new treatment combinations.

In future, any country with high rates of TB and HIV co-infection will have to design its programmes in a single unified application for joint TB and HIV programmes.

Colleen Daniels of Treatment Action Group challenged the delegates assembled to be more ambitious and aim for zero TB deaths, zero new infections and zero suffering and stigma.